First patients test new cancer drug in early safety trial
Disease control
Terminated
This was an early-stage study to test the safety of a new drug called KD033 in people with advanced solid tumors that had spread or could not be removed by surgery. The main goal was to find a safe dose by giving the drug to small groups of people at increasing levels. Researcher…
Phase: PHASE1 • Sponsor: Kadmon, a Sanofi Company • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC